Balanços • Novartis

NVS

A Novartis cria e fabrica fármacos inovadores. As principais áreas de desenvolvimento de fármacos são oncologia, doenças raras, neurociência, imunologia, cardiometabólica e medicina tradicional. A empresa vende seus produtos globalmente, com quase um terço da receita total nos EUA.

Tabela de balanços completa e atualizada com os principais indicadores financeiros: Lucro Líquido, Receita, EBTIDA, Margem, ROE, Dividendos

Ano	Receita Líq	EBITDA	Lucro Líq	Mrg Líq	LPA Dil	Patrimônio	ROE	Dív Líq Aj	DL/EBITDA Aj	FCO Aj	Capex	FCF	FCL Aj	Recompra	Dividendo	Payout	DY
12/2016	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2017	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2018	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2019	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2020	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
12/2021	43,974	15,615	01,345	55%	11	67,655	36%	868	0.06	14,371	-2,556	-16,264	11,815	-3,057	-7,368	31%	4%
12/2022	43,461	14,911	0,234	16%	3.2	59,342	12%	7,245	0.49	13,445	-2,239	-20,562	11,206	-10,652	-7,506	110%	4%
12/2023	46,660	18,152	01,345	32%	7.1	46,667	32%	10,183	0.56	13,593	-2,753	-14,278	10,840	-8,719	-7,255	49%	3.5%
12/2024	51,722	20,658	01,345	23%	5.9	44,046	27%	16,141	0.78	16,575	-3,814	-11,742	12,761	-8,331	-7,624	64%	3.9%
12/2025	56,674	22,919	01,345	25%	7.2	46,130	30%	21,947	0.96	18,048	-3,900	-14,867	14,148	-9,212	-7,818	56%	2.9%

Para ver a tabela completa, você precisa ser Premium.